613 related articles for article (PubMed ID: 2426362)
21. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
22. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
King CA; Wills MR; Hamblin TJ; Stevenson FK
Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
[TBL] [Abstract][Full Text] [Related]
23. Idiotypic vaccination as a treatment for a B cell lymphoma.
George AJ; Folkard SG; Hamblin TJ; Stevenson FK
J Immunol; 1988 Sep; 141(6):2168-74. PubMed ID: 3049800
[TBL] [Abstract][Full Text] [Related]
24. T cell-induced Ig allotypic suppression in mice. II. Both CD4+ CD8- and CD4- CD8+ T cell subsets from sensitized Igha mice are required to induce suppression of Igh-1b allotype expression.
Benaroch P; Bordenave G
J Immunol; 1989 Jan; 142(1):1-7. PubMed ID: 2521230
[TBL] [Abstract][Full Text] [Related]
25. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
Benvenuti F; Burrone OR; Efremov DG
Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576
[TBL] [Abstract][Full Text] [Related]
26. A private idiotype can become recurrent through genetic recombination and gene(s) unlinked to the Igh locus governs its expression.
Mertens F; Berek C; Andris F; Willems F; Brait M; Miller R; Riblet RJ; Slaoui M; Urbain J
Eur J Immunol; 1990 Aug; 20(8):1815-23. PubMed ID: 2120064
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the presence of idiotype-bearing regulatory T cells in which idiotype expression does not show linkage to either IgH alleles or the MHC.
Singhai R; Weaver M; Sikora L; Levy JG
Immunology; 1984 Apr; 51(4):743-54. PubMed ID: 6423526
[TBL] [Abstract][Full Text] [Related]
28. Igh-C allotype-linked control of anti-DNA production and clonotype expression in mice infected with Plasmodium yoelii.
Yoshida H; Fossati L; Yoshida M; Abdelmoula M; Herrera S; Merino J; Lambert PH; Izui S
J Immunol; 1988 Sep; 141(6):2125-31. PubMed ID: 3139752
[TBL] [Abstract][Full Text] [Related]
29. Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.
Krolick KA; Isakson PC; Uhr JW; Vitetta ES
J Immunol; 1979 Nov; 123(5):1928-35. PubMed ID: 385772
[TBL] [Abstract][Full Text] [Related]
30. Enhancement in Igha mouse strains of the "natural" suppressive activity of normal T splenocytes against the expression of Igh-1b allotype. I. Molecular aspects of the chronic suppression obtained.
Benaroch P; Bordenave G
Eur J Immunol; 1988 Jan; 18(1):51-8. PubMed ID: 2964374
[TBL] [Abstract][Full Text] [Related]
31. Recognition of an Igh-linked histocompatibility antigen, H-40, on B-cell tumors by cytotoxic T lymphocytes.
Forman J; Ciavarra R; Henderson LA
Surv Immunol Res; 1985; 4(1):41-7. PubMed ID: 3923586
[TBL] [Abstract][Full Text] [Related]
32. A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG.
Reitan SK; Hannestad K
Eur J Immunol; 1995 Jun; 25(6):1601-8. PubMed ID: 7614988
[TBL] [Abstract][Full Text] [Related]
33. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
34. Hapten-specific responses to the phenyltrimethyl-amino hapten. I. Evidence for idiotype-anti-idiotype interactions in delayed-type hypersensitivity in mice.
Jayaraman S; Bellone CJ
Eur J Immunol; 1982 Apr; 12(4):272-7. PubMed ID: 6178599
[TBL] [Abstract][Full Text] [Related]
35. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
[TBL] [Abstract][Full Text] [Related]
37. B cell dependence of the congeneic barrier towards idiotype-carrying cells.
Bösing-Schneider R; Selinka HC; Lehle G
Eur J Immunol; 1986 Nov; 16(11):1401-5. PubMed ID: 3096744
[TBL] [Abstract][Full Text] [Related]
38. A new cross-reactive idiotype-defined family in the phthalate humoral immune response of mice. I. Linkage of VH-Xmp to IgCH allotype locus and mapping with respect to other known VH genes.
Luo SC; Bankert RB
J Immunol; 1987 Apr; 138(7):2311-5. PubMed ID: 3104458
[TBL] [Abstract][Full Text] [Related]
39. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
George AJ; Spellerberg MB; Stevenson FK
J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
